Dongcheng Pharmaceutical Gets NMPA Green Light for PSMA PET Imaging Drug
China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) announced it has received approval from...
CanSino Biologics Launches Menhycia Meningococcal Vaccine in Six Provinces
China-based CanSino Biologics (HKG: 6185) announced the launch of its ACYW135 Meningococcal Conjugate Vaccine (CRM197)...
Mabwell Bioscience Gets FDA Approval for Nectin-4 ADC 9MW2821 in Solid Tumors
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) announced it has received approval from the...
LaNova Medicines Gets FDA Green Light for LM-305 Myeloma Study
Shanghai-based cancer therapy developer LaNova Medicines Ltd announced it has received approval from the U.S....
Sanofi’s Q2 Earnings Show 8.1% Global Sales Growth, Led by Dupixent and China Expansion
France-based Sanofi (NASDAQ: SNY) reported Q2 2022 global sales of EUR 10.1 billion (USD 10.3...
CSPC Pharmaceutical’s Albumin-Bound Docetaxel Receives Orphan Drug Designation for Gastric Cancer
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) announced that it has received an orphan drug...
Hybio Pharmaceutical’s Liraglutide Filing Accepted by NMPA, Becomes Domestic Leader in GLP-1 Analog
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) announced that its market filing for liraglutide, a...
Roche’s Rozlytrek Wins NMPA Approval for NTRK Fusion Gene-Positive Tumors
Swiss pharmaceutical giant Roche announced that it has received marketing approval from the National Medical...
Kira Pharmaceuticals’ KP104 Receives Orphan Drug Designation for PNH Treatment
Sino-US biotech Kira Pharmaceuticals announced that it has received an Orphan Drug Designation (ODD) from...
Shenzhen Unveils Measures to Boost Biomedical and Medical Device Industries
Shenzhen’s municipal Development and Reform Commission has released a series of measures to promote the...
Merck’s Q2 Sales Surge 31% to USD 14.6B, Led by Keytruda and China Growth
US-based Merck, Sharp & Dohme (MSD, NYSE: MRK) reported Q2 2022 global sales of USD...
Takeda’s Alunbrig Prescribed in China for ALK+ NSCLC Treatment
Japan-based Takeda Pharmaceutical Co., Ltd (TYO: 4502) announced that its lung cancer therapy Alunbrig (brigatinib)...
Cosmo Pharma’s Winlevi Cream Secures Greater China Licensing Deal with 3SBio
Ireland-based Cosmo Pharmaceuticals NV (SWX: COPN) and China’s 3SBio Inc. (HKG: 1530) have signed a...
PerkinElmer and SCUT Launch Joint Translational Medicine Center
US-based PerkinElmer and China’s South China University of Technology (SCUT) have officially launched their joint...
Sun Pharma’s Bicalutamide Supply Suspended in Multiple Chinese Regions
India-based Sun Pharma has suspended the supply of its bicalutamide to Beijing, Tianjin, Jilin, Shanghai,...
MabPharm’s CMAB015 Biosimilar Receives NMPA Approval for Clinical Study
Taizhou-based monoclonal antibody (mAb) biosimilars specialist MabPharm Ltd (HKG: 2181) announced that it has received...
CSPC Jushi Biopharm’s SYSA1801 ADC Secures Licensing Deal with Elevation Oncology
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) announced that its subsidiary, CSPC Jushi Biopharmaceutical Co.,...
CDE Releases 61st Batch of Generic Reference Preparations, 34 New Specs Added
The Center for Drug Evaluation (CDE) has released the 61st batch of chemical generic reference...
Immunochina Pharmaceuticals Secures CAR-T Production License in Beijing
Beijing-based Immunochina Pharmaceuticals has obtained a Drug Production License for its chimeric antigen receptor (CAR)...
Kolo Medical Raises RMB 100M in Series B2 to Launch High-Frequency Ultrasound Imaging System
Suzhou-based Kolo Medical Inc., a leader in next-generation semiconductor ultrasound CMUT (Capacitive Micromachined Ultrasonic Transducer)...